News

June 8, 2022

Glympse to Present Two Posters Demonstrating Novel Protease Biosensor Diagnostic Platform Detection of Hepatocellular Carcinoma at EASL ILC 2022

October 24, 2022

Sunbird Bio Appoints Peter Maimonis, Ph.D., as Chief Technology Officer

October 25, 2022

Glympse to Present Data Demonstrating Sensitive Detection of Hepatocellular Carcinoma at AASLD The Liver Meeting 2022

November 7, 2022

Sunbird Bio Will Be Presenting a Poster at CTAD 2022

August 9, 2023

Sunbird Bio Merges with Glympse Bio to Accelerate Development of Proprietary Protein-Based Diagnostic Technologies